BioWorld Asia

July 1, 2009

UK Committing £150M to Grow Biotech Innovation, Start-ups

LONDON — The UK government is putting in £150 million (US$248 million) as a cornerstone investor in what it hopes will become a £1 billion fund for biotech and other high-tech start-ups over the next 10 years. (BioWorld International) Read More

Clavis' Promising AML Data, Pipeline Helps Bring in $20M

Serotonin Linked to Maternal Behavior in Knockout Study

Alizyme Seeking Funds to Stay Afloat After Missed Milestones

Irish Translational Oncology Research Initiative Gets $7.8M

Cytox Boosting Biomarker Work in Alzheimer's with $1M Funding

Vectura Getting $7.5M Payment as NVA237 Starts Phase III Trial

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

Elderly hands holding broken brain structure

Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

BioWorld Science

Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...

Capital remains selective in ‘barbell’ biotech market

BioWorld

Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...

Brush scrubbing brain figurine with soap

PSB-229 reduces plaque burden in Alzheimer’s models

BioWorld Science

Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...